FDA pharmacologic class
Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme
2 medicines are in FDA's class of hydrolytic lysosomal neutral glycosphingolipid-specific enzymes: agalsidase beta (Fabrazyme) and pegunigalsidase alfa (Elfabrio). 0 of the 2 are listed from generic labelers (FDA NDC Directory, October 8, 2026).
Which medicines are hydrolytic lysosomal neutral glycosphingolipid-specific enzyme?
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Agalsidase beta | Fabrazyme | none listed | n/a | Yes | No current entry | 0 |
| Pegunigalsidase alfa | Elfabrio | none listed | n/a | Yes | No current entry | 0 |
Source: FDA Established Pharmacologic Class (NDC Directory, openFDA); CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)